Clinical Trials Logo

Filter by:
NCT ID: NCT05382299 Recruiting - Clinical trials for Triple Negative Breast Cancer

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

ASCENT-03
Start date: July 20, 2022
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.

NCT ID: NCT05382286 Recruiting - Clinical trials for Triple Negative Breast Cancer

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

ASCENT-04
Start date: July 25, 2022
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).

NCT ID: NCT05382169 Recruiting - Clinical trials for Ehlers Danlos Hypermobile Syndrome

Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders

SAMED
Start date: September 28, 2022
Phase:
Study type: Observational

The aim of the study is to confirm the association between hypermobile Ehlers Danlos syndrome (hEDS) and mast cell activation syndrome (MCAS) in patients with digestive disorders managed in allergology departments.

NCT ID: NCT05382156 Recruiting - Clinical trials for Endogenous Cushing's Syndrome

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

LINC6
Start date: June 13, 2022
Phase:
Study type: Observational

This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome

NCT ID: NCT05381883 Not yet recruiting - COVID-19 Pandemic Clinical Trials

Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments

SILVER NA
Start date: September 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is identify the psychological impact of the coronavirus-19 pandemic on professionals in residential care facilities for old people and home help professionals in New-Aquitaine by : 1. Large-scale screening for the prevalence of mental health disorders among staff. 2. Identification of vulnerability and resilience factors. 3. Improving access to early care for affected professionals.

NCT ID: NCT05381857 Completed - Healthy Subjects Clinical Trials

Genetic & Environmental Determinants Of Immune Phenotype Variance: A Longitudinal Assessment

MI-V3
Start date: March 15, 2022
Phase:
Study type: Observational

Effects of aging, genetics and environmental exposures on immune variation in a previously well-defined healthy population (NCT03905993).

NCT ID: NCT05381844 Recruiting - HIV-1-infection Clinical Trials

Quantification of Antisense HIV RNA in Patients

Start date: October 20, 2022
Phase:
Study type: Observational

The objective of this study is to quantify the expression levels of the HIV-1 unspliced sense transcript and of total HIV-1 antisense transcripts in PBMCs of HIV-1-infected persons, either still untreated or virologically controlled on treatment, and to investigate their correlations with the HIV reservoir as assessed by the quantification of total and integrated HIV-1 DNA.

NCT ID: NCT05381259 Recruiting - Clinical trials for Horticultural Therapy

Effectiveness of Hortitherapy on the Immediate Well-being of Elderly People With Alzheimer's Disease or Related in Day Care

Hortitherapy
Start date: May 4, 2022
Phase: N/A
Study type: Interventional

Currently, there are an estimated 47 million people with dementia worldwide, with approximately 10 million new cases diagnosed each year. This figure is expected to triple to 130 million in 2050. In France, the number of dementia cases is estimated at 754,000 and could reach 1,813,000 in 2050. In a recent literature review, researchers highlighted the many benefits of horticultural therapy and garden environments for people with Alzheimer's or cognitive disorders. They include: alleviating pain, improving attention, decreasing stress, relieving agitation, decreasing the use of medications, such as antipsychotics, as well as reducing falls. Gardening offers a non-pharmacological approach to achieving these goals and could improve the quality of life for people with Alzheimer's disease or another dementia. As part of a care solution, support services that include social activities, such as gardening, reduce the need for more intrusive and expensive care solutions. The objective of this research is to evaluate the impact of horticultural

NCT ID: NCT05380414 Recruiting - Clinical trials for Metastatic Pancreatic Cancer

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The proposal is to implement a molecular screening program for advanced/metastatic pancreatic cancer patients before the initiation of 1st line treatment in order to allow a better selection of patients for rationale personalized medicine with targeted agents and/or combination involving a chemotherapy backbone.

NCT ID: NCT05380310 Not yet recruiting - Medical Device Clinical Trials

Impact on the Time to Diagnosis of Serious Postoperative Complications by a Controlled Connected Medical Device

SMARTANGEL
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Post-operative mortality in case of scheduled surgery is 3% in France (Lancet 2013) mainly due to cardiovascular or respiratory complications, by decompensation of pre-existing pathologies. Complications due to the medical practice are the third cause of morbidity (BMJ, 2016). More than half are preventable and are mainly observed in surgical patients. In conventional hospitalization, excluding intensive care, monitoring is done discontinuously for most of the patients, which does not allow early diagnosis of a vital cardiovascular or respiratory failure. Diagnosis and late treatment do not allow good recovery. The early identification of a vital failure by the continuous monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) would allow faster management by the hospital staff and a reduction in immediate and possibly delayed postoperative mortality.